English

Research and Development

SSI is one of Denmark’s largest research institutions in the health sector.
More about SSI's research and development

R and DSSI is one of Denmark’s largest research institutions in the health sector
Contract ServicesSSI provides contract work within our core activities and competences
Job and CareerRead about SSI as a workplace and meet some of our employees
EPI-NEWSNational surveillance of communicable diseases
Girl in the rain

New mission and strategy

SSI has produced a new strategy with a focus on infectious disease preparedness, biobanking and biomarkers, and research. Read more about SSI's new strategy...
Danish National Biobank

The Danish National Biobank

The Danish National Biobank gives scientists from Denmark and abroad overview and access to more than 16 million biological samples in both existing and future collections. Read more about the Danish National Biobank...
Free measles vaccination for non-immune adults
12-04-2018
On 1 April 2018, an offer of free measles vaccination for adults was introduced. You are covered by the offer if you have not p...
Measles in Copenhagen
11-04-2018
A 6-month-old child living in Copenhagen has tested positive for measles.
Acute and chronic hepatitis C in Denmark, 2018
11-04-2018
The number of hepatitis C cases notified in Denmark is decreasing.

More news...

EPI-NEWS, No 15 - 2018
Salmonella and Campylobacter infections 2016-17 Questionnaire survey on the sources of infection for STEC and HUS
EPI-NEWS, No 13/14 - 2018
Free measles vaccination for non-immune adults
EPI-NEWS, No 12 - 2018
Acute and chronic hepatitis C Measles in Copenhagen Lack of hepatitis B vaccines The temporary vaccination programme will co...
EPI-NEWS, No 11 - 2018
Hepatitis A virus outbreak due to Iranian dates
EPI-NEWS, No 10 - 2018
Hepatitis B, acute and chronic 2017
Boys who feel attracted to boys are not eligible for free HPV vaccination at their GP

More EPI-NEWS...

SSI receives EUR 13.8 million grant from EDCTP to test new tuberculosis (TB) vaccine
21-03-2018
Statens Serum Institut (SSI) in Copenhagen Denmark has been granted a sum of EUR 13.8 million from the European & Developing Countries Cl...
Scientist at SSI receives a grant for further development of a vaccine against resistant enteropathogen
22-12-2017
Scientists at SSI have developed a new potential vaccine against infections from the enteropathogen, Clostridium difficile (CD).
Sweden and Finland are more successful in the fight against tuberculosis than Denmark
09-11-2017
The number of tuberculosis cases among Swedish and Finnish indigenous citizens falls faster than in Denmark shows a new Nordic survey.
Increase in hospital admissions for infections following simultaneous vaccination with MMR and DTaP-IPV-Hib among Danish children
14-11-2016
New research from CVIVA shows that Danish children, who have received the live MMR vaccine together with the non-live DTaP-IPV-Hib vaccin...

More R and D News...

Available Positions:

Currently, we have no available positions.

Statens Serum Institut         

5 Artillerivej

DK 2300 Copenhagen S

T  +45 3268 3268

F  +45 3268 3868